Trial intelligence / Profile preview

Persistence of hepatitis B vaccine-induced immunity and response to booster in children

2008-004785-98Phase 4Terminated

Sponsor
University of Oxford
Start
Jan 2009
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of hepatitis B vaccine recombinant in hepatitis B (HBV), sponsored by University of Oxford. Started Jan 2009; status: terminated.

02

Drugs

hepatitis B vaccine recombinant
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on 2008-004785-98.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-004785-98.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call